Nomura Holdings’s Medifast MED Stock Holding History

Nomura Holdings’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,000	Closed	-$851K	–	2210
2021 Q1	$851K	Buy	+4,000	New	+$957K	﹤0.01%	1159
2020 Q3	–	Sell	-45,458	Closed	-$6.3M	–	1390
2020 Q2	$6.3M	Hold	45,458	–	–	0.02%	339
2020 Q1	$2.83M	Hold	45,458	–	–	0.01%	406
2019 Q4	$4.98M	Buy	+45,458	New	+$4.4M	0.02%	447
2015 Q3	–	Sell	-7,901	Closed	-$256K	–	1837
2015 Q2	$256K	Sell	7,901 -3,109	-28%	-$98.6K	﹤0.01%	1516
2015 Q1	$330K	Buy	+11,010	New	+$349K	﹤0.01%	1275
2014 Q4	–	Sell	-15,144	Closed	-$498K	–	2530
2014 Q3	$498K	Buy	+15,144	New	+$465K	﹤0.01%	1824
2014 Q2	–	Sell	-10,948	Closed	-$316K	–	2924
2014 Q1	$316K	Sell	10,948 -9,883	-47%	-$265K	﹤0.01%	2047
2013 Q4	$544K	Sell	20,831 -2,213	-10%	-$56.7K	﹤0.01%	1238
2013 Q3	$620K	Sell	23,044 -271	-1%	-$7.25K	﹤0.01%	1290
2013 Q2	$602K	Buy	+23,315	New	+$612K	﹤0.01%	1214

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nomura Holdings's MED Position: Q2 2021 in Review

Nomura Holdings sold out of Medifast (MED) in Q2 2021, closing a stake of 4,000 shares — an estimated $851K sold.

Nomura Holdings first reported a position in MED in Q2 2013 and held it in 11 quarters. The position peaked at $6.3M in Q2 2020. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Nomura Holdings reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Nomura Holdings sold 4,000 Medifast shares in Q2 2021, an estimated $851K.
Nomura Holdings first reported a position in Medifast in Q2 2013 and held it in 11 quarters.
Nomura Holdings's Medifast position peaked at $6.3M in Q2 2020.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.